| P50 | author | Rishi R Lulla | Q95991384 |
| | Sabine Müller | Q89245124 |
| P2093 | author name string | C David James | |
| | Jann N Sarkaria | |
| | Stewart Goldman | |
| | Craig Horbinski | |
| | Michael D Prados | |
| | Rintaro Hashizume | |
| | Daphne A Haas-Kogan | |
| | Andrew P Mazar | |
| | Todd Waldman | |
| | Shi-Yuan Cheng | |
| | Alexander H Stegh | |
| | Ali Zhang | |
| | Amanda M Saratsis | |
| P2860 | cites work | Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts | Q27851556 |
| | Targeting CDK4 and CDK6: From Discovery to Therapy | Q28082912 |
| | Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors | Q28294240 |
| | PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma | Q28533981 |
| | A human brainstem glioma xenograft model enabled for bioluminescence imaging | Q33599189 |
| | Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. | Q33968055 |
| | Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing | Q34132814 |
| | Clonogenic assay of cells in vitro. | Q34615431 |
| | Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models | Q34913322 |
| | p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors | Q35133362 |
| | Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression | Q35545894 |
| | p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells | Q36048184 |
| | Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells | Q36377759 |
| | The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity | Q36416243 |
| | Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells | Q36544065 |
| | Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts. | Q37412251 |
| | Targeting cell cycle and hormone receptor pathways in cancer. | Q37502364 |
| | FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer | Q38577772 |
| | Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo | Q38806736 |
| | Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria | Q40044872 |
| | Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures | Q40244447 |
| | Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. | Q40440656 |
| | Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. | Q40492303 |
| | P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells | Q40618783 |
| | Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging | Q41969010 |
| | Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme | Q42124124 |
| | Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel | Q43491437 |
| | Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis | Q43606948 |
| | Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. | Q44083876 |
| | Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors | Q44214973 |
| | A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. | Q53607571 |
| | Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors | Q86406352 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P921 | main subject | glioblastoma | Q282142 |
| | atypical teratoid rhabdoid tumor | Q631904 |
| | DNA damage | Q5205747 |
| | rhabdoid tumor | Q6743515 |
| | xenograft | Q64148587 |
| P304 | page(s) | 1519-1528 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth | |
| P478 | volume | 18 | |